128 related articles for article (PubMed ID: 36204993)
1. Endothelin type A receptor blockade attenuates aorto-caval fistula-induced heart failure in rats with angiotensin II-dependent hypertension.
Kala P; Gawrys O; Miklovič M; Vaňourková Z; Škaroupková P; Jíchová Š; Sadowski J; Kompanowska-Jezierska E; Walkowska A; Veselka J; Táborský M; Maxová H; Vaněčková I; Červenka L
J Hypertens; 2023 Jan; 41(1):99-114. PubMed ID: 36204993
[TBL] [Abstract][Full Text] [Related]
2. Effect of angiotensin-converting enzyme blockade, alone or combined with blockade of soluble epoxide hydrolase, on the course of congestive heart failure and occurrence of renal dysfunction in Ren-2 transgenic hypertensive rats with aorto-caval fistula.
Kala P; Sedláková L; Škaroupková P; Kopkan L; Vaňourková Z; Táborský M; Nishiyama A; Hwang SH; Hammock BD; Sadowski J; Melenovský V; Imig JD; Červenka L
Physiol Res; 2018 Jul; 67(3):401-415. PubMed ID: 29527914
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of soluble epoxide hydrolase counteracts the development of renal dysfunction and progression of congestive heart failure in Ren-2 transgenic hypertensive rats with aorto-caval fistula.
Červenka L; Melenovský V; Husková Z; Škaroupková P; Nishiyama A; Sadowski J
Clin Exp Pharmacol Physiol; 2015 Jul; 42(7):795-807. PubMed ID: 25969338
[TBL] [Abstract][Full Text] [Related]
4. Endothelin type A receptor blockade increases renoprotection in congestive heart failure combined with chronic kidney disease: Studies in 5/6 nephrectomized rats with aorto-caval fistula.
Kala P; Vaňourková Z; Škaroupková P; Kompanowska-Jezierska E; Sadowski J; Walkowska A; Veselka J; Táborský M; Maxová H; Vaněčková I; Červenka L
Biomed Pharmacother; 2023 Feb; 158():114157. PubMed ID: 36580726
[TBL] [Abstract][Full Text] [Related]
5. Roles of renin-angiotensin and endothelin systems in development of diastolic heart failure in hypertensive hearts.
Yamamoto K; Masuyama T; Sakata Y; Mano T; Nishikawa N; Kondo H; Akehi N; Kuzuya T; Miwa T; Hori M
Cardiovasc Res; 2000 Aug; 47(2):274-83. PubMed ID: 10946064
[TBL] [Abstract][Full Text] [Related]
6. End-organ damage in hypertensive transgenic Ren-2 rats: influence of early and late endothelin receptor blockade.
Vernerová Z; Kujal P; Kramer HJ; Bäcker A; Cervenka L; Vaneckova I
Physiol Res; 2009; 58 Suppl 2():S69-S78. PubMed ID: 20131938
[TBL] [Abstract][Full Text] [Related]
7. Renal Sympathetic Denervation Attenuates Congestive Heart Failure in Angiotensin II-Dependent Hypertension: Studies with Ren-2 Transgenic Hypertensive Rats with Aortocaval Fistula.
Honetschlagerová Z; Gawrys O; Jíchová Š; Škaroupková P; Kikerlová S; Vaňourková Z; Husková Z; Melenovský V; Kompanowska-Jezierska E; Sadowski J; Kolář F; Novotný J; Hejnová L; Kujal P; Červenka L
Kidney Blood Press Res; 2021; 46(1):95-113. PubMed ID: 33530085
[TBL] [Abstract][Full Text] [Related]
8. Effects of Epoxyeicosatrienoic Acid-Enhancing Therapy on the Course of Congestive Heart Failure in Angiotensin II-Dependent Rat Hypertension: From mRNA Analysis towards Functional In Vivo Evaluation.
Kala P; Miklovič M; Jíchová Š; Škaroupková P; Vaňourková Z; Maxová H; Gawrys O; Kompanowska-Jezierska E; Sadowski J; Imig JD; Falck JR; Veselka J; Červenka L; Aiglová R; Vícha M; Gloger V; Táborský M
Biomedicines; 2021 Aug; 9(8):. PubMed ID: 34440257
[TBL] [Abstract][Full Text] [Related]
9. Effects of combined endothelin A receptor and renin-angiotensin system blockade on the course of end-organ damage in 5/6 nephrectomized Ren-2 hypertensive rats.
Vaněčková I; Kujal P; Husková Z; Vaňourková Z; Vernerová Z; Certíková Chábová V; Skaroupková P; Kramer HJ; Tesař V; Červenka L
Kidney Blood Press Res; 2012; 35(5):382-92. PubMed ID: 22487948
[TBL] [Abstract][Full Text] [Related]
10. Sex-linked differences in the mortality in Ren-2 transgenic hypertensive rats with aorto-caval fistula: effects of treatment with angiotensin converting enzyme alone and combined with inhibitor of soluble epoxide hydrolase.
Kala P; Červenka L; Škaroupková P; Táborský M; Kompanowska-Jezierska E; Sadowski J
Physiol Res; 2019 Aug; 68(4):589-601. PubMed ID: 31177795
[TBL] [Abstract][Full Text] [Related]
11. The treatment with trandolapril and losartan attenuates pressure and volume overload alternations of cardiac connexin-43 and extracellular matrix in Ren-2 transgenic rats.
Sykora M; Kratky V; Cervenka L; Kopkan L; Tribulova N; Szeiffova Bacova B
Sci Rep; 2023 Nov; 13(1):20923. PubMed ID: 38017033
[TBL] [Abstract][Full Text] [Related]
12. Addition of ET(A) receptor blockade increases renoprotection provided by renin-angiotensin system blockade in 5/6 nephrectomized Ren-2 transgenic rats.
Čertíková Chábová V; Vernerová Z; Kujal P; Husková Z; Škaroupková P; Tesař V; Kramer HJ; Kompanowska-Jezierska E; Walkowska A; Sadowski J; Červenka L; Vaněčková I
Life Sci; 2014 Nov; 118(2):297-305. PubMed ID: 24373834
[TBL] [Abstract][Full Text] [Related]
13. Sex-linked differences in the course of chronic kidney disease and congestive heart failure: a study in 5/6 nephrectomized Ren-2 transgenic hypertensive rats with volume overload induced using aorto-caval fistula.
Červenka L; Škaroupková P; Kompanowska-Jezierska E; Sadowski J
Clin Exp Pharmacol Physiol; 2016 Oct; 43(10):883-95. PubMed ID: 27385471
[TBL] [Abstract][Full Text] [Related]
14. AT
Kratky V; Vanourkova Z; Sykora M; Bacova BS; Hruskova Z; Kikerlova S; Huskova Z; Kopkan L
Sci Rep; 2021 Feb; 11(1):4271. PubMed ID: 33608612
[TBL] [Abstract][Full Text] [Related]
15. The impact of phosphodiesterase-5 inhibition or angiotensin-converting enzyme inhibition on right and left ventricular remodeling in heart failure due to chronic volume overload.
Tykvartova T; Miklovic M; Kotrc M; Skaroupkova P; Kazdova L; Trnovska J; Skop V; Kolar M; Novotny J; Melenovsky V
Pharmacol Res Perspect; 2024 Feb; 12(1):e1172. PubMed ID: 38284173
[TBL] [Abstract][Full Text] [Related]
16. Altered Renal Vascular Responsiveness to Vasoactive Agents in Rats with Angiotensin II-Dependent Hypertension and Congestive Heart Failure.
Vacková Š; Kikerlová S; Melenovsky V; Kolář F; Imig JD; Kompanowska-Jezierska E; Sadowski J; Červenka L
Kidney Blood Press Res; 2019; 44(4):792-809. PubMed ID: 31430751
[TBL] [Abstract][Full Text] [Related]
17. Endothelin receptor blockade does not affect blood pressure or angiotensin II levels in CYP1A1-Ren-2 transgenic rats with acutely induced hypertension.
Vanourková Z; Kramer HJ; Erbanová M; Bäcker A; Cervenka L; Husková Z; Chábová VC; Tesar V; Dvorák P; Malý J; Vanecková I
Vascul Pharmacol; 2009; 50(5-6):194-9. PubMed ID: 19563737
[TBL] [Abstract][Full Text] [Related]
18. Renin-angiotensin system blockade alone or combined with ET
Sedláková L; Čertíková Chábová V; Doleželová Š; Škaroupková P; Kopkan L; Husková Z; Červenková L; Kikerlová S; Vaněčková I; Sadowski J; Kompanowska-Jezierska E; Kujal P; Kramer HJ; Červenka L
Clin Exp Hypertens; 2017; 39(2):183-195. PubMed ID: 28287881
[TBL] [Abstract][Full Text] [Related]
19. Late-onset endothelin receptor blockade in hypertensive heterozygous REN-2 transgenic rats.
Vernerová Z; Kramer HJ; Bäcker A; Cervenka L; Opocenský M; Husková Z; Vanourková Z; Eis V; Chábová VC; Tesar V; Malý J; Vanecková I
Vascul Pharmacol; 2008; 48(4-6):165-73. PubMed ID: 18372220
[TBL] [Abstract][Full Text] [Related]
20. Moderate additive effects of endothelin receptor A blockade in Ren-2 transgenic rats subjected to various types of RAS blockade.
Vaněčková I; Řezáčová L; Kuneš J; Zicha J
Life Sci; 2016 Aug; 159():127-134. PubMed ID: 26775568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
